ITCI
Intra-Cellular Therapies Inc
Price:  
127.56 
USD
Volume:  
1,562,881.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ITCI Stock Forecast & Price Target

ITCI Stock Price Forecast

The average stock forecast for Intra-Cellular Therapies Inc (ITCI) in the next 12 months is 128.71 USD. This price target corresponds to an upside of 1.33%. The range of stock forecasts for ITCI is 87.87 - 147.00 USD. Based on the ratings of 19 analysts, the consensus recommendation for ITCI is HOLD.
Target Low Average Median High
Price (USD) 87.87 128.71 134.64 147.00
Upside -30.82% 1.33% 6.01% 15.74%

Recommendation Trends

The latest consensus rating for ITCI is "HOLD". This is the average recommendation of 19 analysts: 0 strong sell, 0 sell, 10 hold, 7 buy, 2 strong buy. In the previous period, 22 analysts also majorly recommmended "BUY" for ITCI.

ITCI Financial Stock Forecast

Revenue This Year
688.57M
48.28%
from 464.37M
Revenue Next Year
945.71M
37.34%
from 688.57M
EPS This Year
-0.72
-45.09%
from -1.32
EPS Next Year
0.38
-152.55%
from -0.72